Author: Michael E. Schatman
Posted on July 14, 2016
High-quality research on the safety and efficacy of medical cannabinoids as pain therapy has long been impeded by an adverse regulatory environment. Even as the prominence of medical marijuana continues to grow—in part due to the public health crisis of opioid abuse—confusion about marijuana for chronic pain prevails. Dr. Schatman outlines what we really know, and what we still don’t.